Insider · CIK 0002058152
Beltran Pedro
Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA
Transactions
7
Companies
1
Filings
6
CIK
0002058152
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-01 | BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment | −$4,125.18 |
| 2026-07-01 | BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment | −$8,166.6 |
| 2026-05-10 | BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-04-01 | BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment | −$9,454.41 |
| 2026-03-10 | BBOTBridgeBio Oncology Therapeutics, Inc.A Award | — |
| 2026-03-10 | BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-08-26 | BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Beltran Pedro0001193125-26-414127SEC(opens sec.gov)
- 4Beltran Pedro0001193125-26-296501SEC(opens sec.gov)
- 4Beltran Pedro0001193125-26-219439SEC(opens sec.gov)
- 4Beltran Pedro0001193125-26-207035SEC(opens sec.gov)
- 4Beltran Pedro0001193125-26-104379SEC(opens sec.gov)
- 4Beltran Pedro0000950170-25-112003SEC(opens sec.gov)
Companies
Address
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 256 EAST GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA, 94080